Log in or Sign up for Free to view tailored content for your specialty!
Scleroderma News
US Supreme Court decision on mifepristone ‘not a victory, but a punt’
On June 13, the U.S. Supreme Court rejected a lawsuit that challenged the FDA’s approach to regulating the abortion pill mifepristone.
Men with systemic sclerosis who smoke face greater excess mortality than women
Men with systemic sclerosis who smoke demonstrate a greater risk for death than women with SSc who smoke, according to a study published in RMD Open.
Log in or Sign up for Free to view tailored content for your specialty!
Racing modified cells against each other in humans may be the next step in gene therapies
The next evolution of gene therapies may involve pitting T cells with different modifications against one another in a “race” inside a human to determine which edits produce the best results against a tumor, an expert panel predicted.
‘Be aggressive’ in detecting, managing interstitial lung disease in early scleroderma
DESTIN, Fla. — Detection and treatment of interstitial lung disease in systemic sclerosis calls for early and aggressive action, according to data presented at the Congress of Clinical Rheumatology East.
'Quelling anxiety' essential for rheumatologists ensuring safe pregnancies
DESTIN, Fla. — Ongoing, frank discussions about reproductive health with patients of childbearing age is critical to safe pregnancy outcomes, according to a presenter at the Congress of Clinical Rheumatology East.
CAR T-cell therapy remains the 'hottest story' in lupus, autoimmune disease
DESTIN, Fla. — Positive results for chimeric antigen receptor T-cell therapy in systemic sclerosis and myositis have added fuel to the fire of recent landmark data in lupus, said a speaker at the Congress of Clinical Rheumatology East.
'The cure is in front of you': The case for stem cell transplants in systemic sclerosis
DESTIN, Fla. — Stem cell transplantation, accompanied by total body radiation, is the only “cure” for progressive systemic sclerosis currently available, according to a speaker at the Congress of Clinical Rheumatology East annual meeting.
‘Subclinical’ left ventricular abnormalities portend lower survival, breathlessness in SSc
Patients with systemic sclerosis who demonstrate left ventricular abnormalities, either overt or “subclinical,” have poorer survival and increased shortness of breath, according to data published in Seminars in Arthritis and Rheumatism.
More than 40% of patients with systemic sclerosis malnourished
As much as 43% of patients with systemic sclerosis are malnourished, while 33% demonstrate severe malnutrition, according to data from an Australian study published in Rheumatology.
ESC scoring tool predicts survival in SSc-associated pulmonary arterial hypertension
The 2022 European Society of Cardiology risk assessment tool, when applied at baseline and follow-up, can accurately predict survival in patients with systemic sclerosis-associated pulmonary arterial hypertension, according to data.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read